Cristina Martinez, APRN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1005 Kane Concourse Ste 203, Bay Harbor Islands, FL 33154 Phone: 786-540-9911 |
Dr. Gloria O'neill, Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 9821 E Bay Harbor Dr Apt 905, Bay Harbor Islands, FL 33154 Phone: 305-450-9651 Fax: 786-535-1164 |
Ms. Dawn Marie Cooperman, NP Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 1251 96th St, Bay Harbor Islands, FL 33154 Phone: 786-301-7218 |
Wanda H Silva, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1045 95th St Ste 100, Bay Harbor Islands, FL 33154 Phone: 305-993-4400 Fax: 305-993-4402 |
Jenelle Camino, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1143 Kane Concourse, Bay Harbor Islands, FL 33154 Phone: 305-861-6881 |
News Archive
Autism Spectrum Therapies, an agency providing comprehensive autism services throughout Southern California, is expanding its services to include speech and language programs and occupational therapy, in addition to behavior therapy. The focus of the new services will be early intervention for children from infancy to age three and developmental catch-up for young children who have fallen behind in any developmental area.
Dance therapy can be a successful method for reaching children and adolescents with problems. This has been shown in a research project at Karlstad University and the University College of Dance in Stockholm, Sweden.
Ethicon, Inc., part of the Johnson & Johnson Medical Devices Companies, announces a strategic collaboration with Touch Surgery to help improve patient outcomes by delivering simulated surgical training based on the safe and efficacious use of Ethicon products in a free mobile app that can reach medical professionals in even remote regions of the world.
Final results of the WIN-R trial,[1] the largest hepatitis C study conducted in U.S. patients, showed that weight-based REBETOL (ribavirin, USP) in combination therapy with PEG-INTRON (peginterferon alfa-2b) achieved significantly higher rates of sustained virologic response (SVR)[2] and lower rates of relapse compared to the combination therapy using a flat dose of ribavirin.
› Verified 1 days ago